Hindustan Unilever Limited (HUL) today announced two strategic moves in its Health & Wellbeing (H&W) business - the full acquisition of Zywie Ventures Private Limited (“OZiva”) and the divestment of its minority stake of 19.8% in Nutritionalab Private Limited, for a consideration of Rs. 824 crores and Rs. 307 crores, respectively.
Since entering the H&W category in 2023, HUL has focused on building a strong presence in this nascent yet fast-growing consumer space. OZiva has delivered strong performance following HUL’s majority investment of 51% — scaling to approximately Rs. 480 crores in 2025 with a growth of c. 130% CAGR in last 2 years by developing a winning portfolio and unlocking significant synergies through HUL’s ecosystem. The Board of Directors of HUL has approved the acquisition of the remaining 49% stake as per the pre-agreed valuation framework, for a consideration of Rs. 824 crores, making OZiva a wholly owned subsidiary of the Company.
In line with its strategy of continued portfolio transformation through fewer, bigger bets, HUL’s Board has approved the sale of its minority stake of 19.8% in Nutritionalab Private Limited to USV Private Limited for a consideration of Rs. 307 crores.
Both transactions are expected to close by March 2026, subject to customary closing conditions.
Priya Nair, CEO and Managing Director, HUL, said: “Health & Wellbeing is an important growth vector for us, driven by rising consumer interest in everyday wellness. By taking full ownership of OZiva, we are doubling down on this exciting space to unlock the next phase of growth. Our decisions today reflect our intent of fewer, bigger bets where we can leverage HUL’s strengths in science, distribution and market development to scale purpose-led brands.”